TELA TELA Bio Inc

Price (delayed)

$0.9001

Market cap

$40.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.79

Enterprise value

$56.37M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 23

TELA Bio Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is ...

Highlights
TELA Bio's EPS has increased by 41% YoY and by 4.8% from the previous quarter
TELA Bio's gross profit has increased by 14% YoY
The company's net income rose by 8% YoY but it fell by 2.6% QoQ
The equity has dropped by 182% since the previous quarter and by 129% year-on-year
TELA Bio's debt has increased by 35% YoY

Key stats

What are the main financial stats of TELA

TELA stock price

How has the TELA Bio stock price performed over time
Intraday
4.66%
1 week
-0.02%
1 month
-17.42%
1 year
-52.12%
YTD
-23.72%
QTD
45.18%

Financial performance

How have TELA Bio's revenue and profit performed over time
Revenue
$80.81M
Gross profit
$54.35M
Operating income
-$33.81M
Net income
-$39.84M
Gross margin
67.3%
Net margin
-49.3%
The operating margin has grown by 25% YoY
TELA Bio's net margin has increased by 19% YoY
The operating income has increased by 15% year-on-year
TELA Bio's gross profit has increased by 14% YoY

Price vs fundamentals

How does TELA's price correlate with its fundamentals

Growth

What is TELA Bio's growth rate over time

Valuation

What is TELA Bio stock price valuation
P/E
N/A
P/B
N/A
P/S
0.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.7
TELA Bio's EPS has increased by 41% YoY and by 4.8% from the previous quarter
The equity has dropped by 182% since the previous quarter and by 129% year-on-year
TELA's price to sales (P/S) is 82% less than its 5-year quarterly average of 3.3 and 24% less than its last 4 quarters average of 0.8
TELA's revenue is up by 13% year-on-year

Efficiency

How efficient is TELA Bio business performance
TELA Bio's ROS has increased by 23% YoY
TELA's ROIC is up by 17% YoY and by 3.5% QoQ
TELA's ROA is up by 9% year-on-year but it is down by 5% since the previous quarter

Dividends

What is TELA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TELA.

Financial health

How did TELA Bio financials performed over time
TELA's total assets is 7% less than its total liabilities
The total liabilities has grown by 27% YoY
The quick ratio is down by 19% since the previous quarter and by 14% year-on-year
The equity has dropped by 182% since the previous quarter and by 129% year-on-year
TELA Bio's debt has increased by 35% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.